Austrian team to develop biochip for screening FH (familial hypercholesterolaemia)
This article was originally published in Clinica
Executive Summary
Austrian researchers are developing a biochip for screening over 600 DNA mutations that they claim cause familial hypercholesterolaemia (FH) - an inherited form of high blood cholesterol. Their work follows the publication of a Dutch study which suggested that DNA analysis targeted at relatives of known sufferers is highly effective in screening for the disorder (see Clinica No 942, p 17).